We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lyme Disease Antibodies Attached to Nanotubes

By LabMedica International staff writers
Posted on 10 Apr 2013
A fast and accurate sensor for a Lyme disease antigen has been developed that may pave the way for a diagnostic device. More...


The potential of antibody-functionalized single-walled carbon nanotube (SWNT) field-effect transistors (FETs) has been examined which may lead to diagnostics that can detect the organism itself.

Scientists at the University of Pennsylvania (Philadelphia, PA, USA) fabricated the device and attached monoclonal Lyme antibodies specific for the Borrelia burgdorferi p41 flagellar antigen (antibodies-online Inc.; Atlanta, GA, USA) and histidine tagged Lyme antigen containing the p41 flagellar immunodominant region which is also known as flagellin (ProSpec; East Brunswick, NJ, USA). Attachment of B. burgdorferi (Lyme) flagellar antibodies to the nanotubes was verified by atomic force microscopy and electronic measurements.

After using atomic-force microscopy to show that antibodies had indeed bound to the exteriors of their nanotube transistors, the investigators tested them electrically to get a baseline reading. They then put the nanotubes in solutions that contained different concentrations of the target Lyme bacteria protein. The smallest concentration the nanotube devices could detect was four ng/mL of protein of solution.

Early diagnosis is critical in treating Lyme disease, nevertheless, nearly one quarter of Lyme disease patients are initially misdiagnosed because currently available serological tests have poor sensitivity and specificity during the early stages of infection. Misdiagnosed patients may go untreated and thus progress to late-stage Lyme disease, where they face longer and more invasive treatments, as well as persistent symptoms.

A.T. Charlie Johnson, PhD, a professor of physics and senior author of the study said, "If we were to do this type of test on a person's blood now, however, we would say the person has the disease. The first thought is that if you detect any protein coming from the Lyme organism in your blood, you are infected and should get treatment right away." The study was published online on February 4, 2013, in the journal Biosensors and Bioelectronics.

Related Links:
University of Pennsylvania
antibodies-online Inc.
ProSpec



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.